Search Ontology:
ChEBI
alpha-Neu5Gc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Gc-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
- Term ID
- CHEBI:142424
- Synonyms
-
- (2S,3R,4E)-2-acylamino-3-hydroxyoctadec-4-en-1-yl 3,5-dideoxy-5-(2-hydroxyacetamido)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-[3,5-dideoxy-5-(2-hydroxyacetamido)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1
- alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine
- alpha-NeuNGc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-NeuNGc-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
- alpha-NeupNGc-(2->3)-beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-[alpha-NeupNGc-(2->3)]-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
- ganglioside GD1a(NeuGc, NeuGc)
- GD1a(NeuGc, NeuGc)
- NeuGc(alpha2-3)Gal(beta1-3)GalNAc(beta1-4)[NeuGc(alpha2-3)]Gal(beta1-4)Glc(beta1-1)Cer
- NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta1-1Cer
- NeuGcalpha2->3Galbeta1->3GalNAcbeta1->4(NeuGcalpha2->3)Galbeta1->4Glc-Cer
- NeuGcalpha2->3Galbeta1->3GalNAcbeta1->4(NeuGcalpha2->3)Galbeta1->4Glcbeta1-1Cer
- Definition
- A sialotetraosylceramide consisting of a branched hexasaccharide made up from two N-glycoloylneuraminyl residues, two galactose residues, one N-acetylgalactosamine residue and a glucose residue at the reducing end attached to the ceramide portion via a beta-linkage.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from alpha-Neu5Gc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Gc-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype where environments contain alpha-Neu5Gc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Gc-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype modified by environments containing alpha-Neu5Gc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Gc-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Human Disease Model